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Abstract
Ionotropic receptors are tightly regulated by second messenger systems and
are often present along with their metabotropic counterparts on a neuron’s
plasma membrane. This leads to the hypothesis that the two receptor subtypes
can interact, and indeed this has been observed in excitatory glutamate and
inhibitory GABA receptors. In both systems the metabotropic pathway aug-
ments the ionotropic receptor response. However, we have found that the
metabotropic GABAB receptor can suppress the ionotropic GABAA receptor
current, in both the in vitro mouse retina and in human amygdala membrane
fractions. Expression of amygdala membrane microdomains in Xenopus
oocytes by microtransplantation produced functional ionotropic and metabo-
tropic GABA receptors. Most GABAA receptors had properties of a-subunit
containing receptors, with ~5% having q-subunit properties. Only GABAA
receptors with a-subunit-like properties were regulated by GABAB receptors.
In mouse retinal ganglion cells, where only a-subunit-containing GABAA
receptors are expressed, GABAB receptors suppressed GABAA receptor cur-
rents. This suppression was blocked by GABAB receptor antagonists, G-protein
inhibitors, and GABAB receptor antibodies. Based on the kinetic differences
between metabotropic and ionotropic receptors, their interaction would sup-
press repeated, rapid GABAergic inhibition.
Introduction
GABA, the major inhibitory transmitter in brain, binds fast-
acting ionotropic GABAARs that function as Cl
 permeable
heteropentameric ion channels. Additionally, GABA acti-
vates slower, metabotropic GABAB G-protein-coupled
receptors (GPCRs) that regulate voltage-gated K+ and Ca2+
channels (Bowery et al. 1980; Kaupmann et al. 1998). As
their activity influences many neural systems and behavioral
states, the GABABR is a major target of therapeutic drugs for
mental disorders and drugs of abuse (Bettler et al. 2004).
Both retina and amygdala express high levels of ionotro-
pic and metabotropic GABA receptors (Li et al. 1996). Reti-
nal ganglion cells possess both GABAARs and GABABRs
(Friedman and Redburn 1990; Koulen et al. 1998), and
GABAergic neurons are essential for image processing in
ganglion cells (Fried et al. 2005). GABAergic transmission is
also crucial for the low firing rate and strong inhibitory tone
in amygdala and projection neurons that target the thalamus
and hypothalamus (Barnard et al. 1998; Lang and Pare
1998; Quirk and Gehlert 2003) and have been linked to emo-
tional behavior, such as anxiety (Lehner et al. 2010).
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GABABRs participate in this action by inhibiting gluta-
matergic cortical input to lateral amygdala, selectively sup-
pressing excitation of principle neurons (Yamada et al.
1999; Pan et al. 2009). The GABABRs also suppress projec-
tion neurons postsynaptically by activating inward rectifying
potassium channels (Huttmann et al. 2006).
The a-subunit containing GABAAR possesses consensus
sequence phosphorylation sites for PKA, PKC, tyrosine,
and calmodulin kinases (Song and Messing 2005). Notably,
PKC reduces the GABAAR current and this is associated
with various serine sites on b- and c-subunits (Kellenberger
et al. 1992; Krishek et al. 1994). An example is serotonin
suppression of GABA currents in prefrontal cortex through
PKC activation (Feng et al. 2001). PKA can either enhance
or suppress GABAAR currents, depending on the b-subunit
of the receptor (McDonald et al. 1998).
The GABABR reduces adenylate cyclase activity (Dutar
and Nicoll 1988; Kamatchi and Ticku 1990; Knight and
Bowery 1996) and modulates PKC (Dutar and Nicoll
1988; Taniyama et al. 1992; Kubota et al. 2003). Conse-
quently, the GABABR can act through a variety of second
messenger cascades to modulate the GABAAR current. In
GABA receptors that contain the d subunit, the GABABR
can increase the tonic current of the GABAAR and pro-
mote inhibition, likely acting by suppressing PKA activity
(Connelly et al. 2013; Tao et al. 2013). This has been
found in dentate gyrus, thalamus, and cerebellum.
A report on the interaction between GABAA and GABAB
receptors in bullfrog dorsal root ganglion neurons was
described in 1997 (Xi et al. 1997), but to our knowledge
there has been no further exploration of this phenomenon.
The purpose of this study was to explore GABA receptor
interactions in two mammalian tissues: native mouse reti-
nal neurons and in tissue derived from human amygdala.
The latter was accomplished by microtransplantation of
plasma membrane from human amygdala into Xenopus
oocytes (Miledi et al. 2006). The in vitro retina preparation
demonstrates this crosstalk between GABAA and GABAB
receptors in the mammalian nervous system; the oocyte
preparation demonstrates the utility of the microtransplan-
tation technique in examining multireceptor activation in
an inaccessible part of the human nervous system. In com-
bination, these experiments indicate that GABABRs may
have a widespread and unanticipated net disinhibitory
action in the mammalian central nervous system.
Materials and Methods
Microtransplantation of membrane
fractions
The microtransplantation method of incorporating
transmitter receptors from native tissue into Xenopus
oocytes was employed. This is an alternative approach for
studying ion channel and receptor properties (Miledi
et al. 2002, 2004, 2006). The method is designed to insert
into the oocytes with already assembled receptors and ion
channels in their native membrane fraction, bypassing the
oocyte’s protein processing machinery elicited by foreign
RNA transfection.
Human amygdala tissue was obtained from four males
and two females autopsied at the University of Kentucky
Alzheimer’s Disease (AD) Center biobank, under the pur-
view of the University of Kentucky IRB (Schmitt et al.
2012), but who had no AD pathology. The postmortem
intervals were all <4 h, and tissues were snap-frozen at
the time of autopsy in liquid nitrogen and then stored at
80°C until use. Membrane fractions were collected fol-
lowing the published protocol (Eusebi et al. 2009).
Briefly, a 500- to 600-mg piece of frozen human amyg-
dala tissue was homogenized in a glass tube containing a
high glucose solution. The homogenized solution was
centrifuged for 15 min at 9400g (Eppendorf Centrifugal
5418) in a cold room, and the supernatant was collected
and ultracentrifuged at 100,000 g (Beckman Coulter
Optima L-90K) for 2 h at 4oC. The pellets (membrane
proteins and lipids) were resuspended in a cold glycine
buffer solution and stored at 80°C.
Freshly harvested Xenopus oocytes were purchased
from the Ecocyte Bioscientific US LLC (Austin, TX).
The oocytes were injected with 41–82 nL of membrane
fraction samples, in which the protein concentrations
were calibrated at 0.5–1 mg/mL, using an autonanoliter
injector – Nanoject II (Drummond Scientific Company).
After 1–2 days, the native membrane proteins embedded
in their natural lipid environment readily incorporated
into surface membranes of the injected oocytes. A sham
control was performed by injection of a glycine buffer
solution.
Electrophysiological recording
The oocytes were placed in the recording chamber and
superfused with modified Barth’s solution containing
(mmol/L): NaCl (115), KCl (2), CaCl2 (1.8), N-2-hydro-
xyethylpiperazine-N’-2-ethanesulfonic acid (HEPES, 5),
pH 7.4, at room temperature. GABA currents were
recorded from individual oocytes using a double-electrode
voltage-clamp amplifier (GeneClamp 500B, Axon Instru-
ments, Inc.). Microelectrodes were pulled to resistances
between 0.7 and 1.5 MΩ when filled with 3.0 mol/L KCl
for voltage and current recordings. Data acquisition and
analysis were performed using Powerlab-LabChat V7 (AD
Instruments). Where applicable, drug–receptor interaction
curves were determined by fitting the experimental data
to a Hill equation:
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I/Imax ¼ [C]n=ð[C]n þ ½EC50nÞ
where I is the current response to a drug concentration
[C], Imax is the current elicited at a saturating drug con-
centration, n is the Hill coefficient, and EC50 (or 1/IC50,
where the reciprocal replaces EC50 in the above equation)
is the concentration at which a half-maximal drug
response is obtained. Average peak current was measured
and presented as mean  SEM of 4–18 sets of data from
different oocyte batches. Significant differences were
determined by unpaired Student’s t-test using Microsoft
Excel. The receptor agonists and antagonists were pre-
pared in the modified Barth’s solution and were super-
fused by a gravity-feed perfusion system.
Whole-cell recording from mouse retinal ganglion cells
was performed with an EPC-10 amplifier and HEKA soft-
ware (HEKA). Briefly, the retina was isolated from 4- to
8-week-old mice and flat mounted on filter paper with
photoreceptors down. The retinal tissue and filter paper
were vertically sectioned in 250–300 lm slices in cold
HEPES-buffered oxygenated MEM solution (Corning). All
procedures were performed in accordance with the provi-
sions of the National Institutes of Health Guide for the
Care and Use of Laboratory Animals, and approved by
the University’s Animal Care Committee.
A single slice was moved to a recording chamber and
superfused constantly with the MEM solution. Voltage-
clamp recordings were made on ganglion cells in the reti-
nal slices. The recording electrodes were filled with an
intracellular solution containing (mmol/L): K-gluconate
120, MgCl2 1, CaCl2 0.5, HEPES 10, EGTA 5, GTP 1,
ATP 5. GABAA and GABAB receptor agonists were briefly
puffed on ganglion cells with a DAD-VM 12 valve mani-
fold superfusion system (ALA Scientific Instruments). All
the chemicals were purchased from Sigma or Tocris.
Immunoantibody labeling
After voltage or current recording, the oocytes were
washed twice with the modified Barth’s solution and fixed
in a 4% paraformaldehyde solution for 45 min at room
temperature followed by washing with the Barth’s solu-
tion. The oocytes were treated in 1% Triton-X100 con-
tained Barth’s solution for 20 min, immersed in the
blocking solution containing 5% goat serum for 2 h, then
incubated overnight at 4°C in solution containing rabbit
monoclonal anti-GBRII (GABAB receptor II, Abcam,
ab75838, 1:1000) and 5% goat serum. After washing with
the Triton-X100 solution the oocytes were incubated with
goat-anti-rabbit Cy-3-conjugated secondary antibody
(1:600) for 1 h in darkness. Immunostained oocytes were
visualized in a Zeiss LSM 700 confocal microscope system
(Munich, Germany).
Results
Characterizing ionotropic GABA receptors
from the human amygdala
GABA responses in human amygdala have not been
reported, so initial experiments were performed to charac-
terize the ionotropic GABA receptor currents. Oocytes
were studied 2–3 days after injection of amygdala mem-
brane fractions. As illustrated in Figure 1A, currents were
elicited by various concentrations of GABA (5–1000 lmol/
L) in transplanted oocytes held at 70 mV. The threshold
concentration for GABA was around 5 lmol/L and maxi-
mum GABA currents were elicited by 500 lmol/L GABA.
The current response to 1000 lmol/L GABA was reduced,
probably due to fast desensitization (darkest trace in
Fig. 1A). Also, a noticeable GABA current decay appeared
when the concentration exceeded 20 lmol/L GABA,
indicative of receptor desensitization. A similar pattern of
dose-dependent currents was induced by muscimol, a
selective a-subunit GABAAR agonist (Fig. 1B). The dose–
response curves of GABA and muscimol are plotted in Fig-
ure 1C; the calculated mean EC50 of GABA and muscimol
were 69 lmol/L (n = 9) and 45 lmol/L (n = 9), respec-
tively. On average, the maximum current amplitudes gen-
erated by saturating concentrations (500 lmol/L) of
GABA and muscimol were 134  21 nA (n = 9) and
189  32 nA (n = 5), respectively, representing a statisti-
cally significant difference (P < 0.01) in the responses to
these agonists.
GABA-elicited currents were recorded at various volt-
ages as designated in Figure 1D. The peak current ampli-
tudes at each voltage are plotted in Figure 1E, showing
that the voltage–current relationship of GABA receptors
was approximately linear with the reversal potential
around 20 mV, corresponding to the Cl equilibrium
potential in Xenopus oocytes (Kusano et al. 1982). In a
negative control, GABA currents were recorded from
oocytes injected with a sham solution, showing that no
endogenous GABA response (Fig. 1F).
Ionotropic GABAARs can be broadly divided into a-sub-
unit containing receptors (the classical GABAARs) and the
more recently discovered q-subunit containing GABAARs
(often called GABACRs). Pharmacological properties of
a-containing GABAARs from human amygdala were stud-
ied using SR95531 (gabazine) and bicuculline, selective
antagonists. These agents were tested against 50 lmol/L
GABA, the approximate EC50 concentration (see Fig. 1C).
The GABA currents were antagonized by either SR95531 or
bicuculline in a dose-dependent manner (Fig. 2A and B).
Picrotoxin, a nonselective blocker of Cl permeable recep-
tors, was also an effective dose-dependent inhibitor (data
not shown). The antagonist dose–response curves shown
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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in Figure 2C indicate that the IC50 of SR95531, bicuculline,
and picrotoxin were 0.6 lmol/L (n = 6), 8 lmol/L
(n = 5), and 10 lmol/L (n = 5), respectively. The concen-
trations needed for maximal inhibition (ICmax) were
approximately 10 lmol/L for SR95531 and 100 lmol/L for
both bicuculline and picrotoxin (Fig. 2C). However, none
of the antagonists fully blocked the GABA-induced current,
generally 10% of the current remained (Fig. 2D). Amyg-
dala is reported to express q-subunit GABAARs (Li et al.
1996; Cunha et al. 2010; Flores-Gracia et al. 2010). CACA
(cis 4-aminocrotonic acid) is a q-subunit GABAAR agonist
(Johnston 1996; Cherubini and Strata 1997). CACA at
100 lmol/L produced a maximal current that was approxi-
mately 9% of the EC50 current produced by 50 lmol/L
GABA, indicating it contributes about 5% of the total
GABA current (Fig 2D).
TPMPA (1,2,5,6-tetrahydropyridin-4-yl methylphos-
phinic acid) is a q-subunit GABAAR antagonist. In exper-
iments in which the a-subunit GABAAR current was
blocked by 200 lmol/L bicuculline, then 100 lmol/L
TPMPA, could partially block the remaining current pro-
duced by 50 lmol/L GABA (Fig. 2E). The current elicited
by 100 lmol/L CACA was partially blocked by TPMPA
(Fig. 2F). Collectively, these data identify a small but sig-
nificant functional q-subunit GABAAR response in human
amygdala. Even 200 lmol/L picrotoxin does not fully
block 50 lmol/L GABA (Fig. 2G), suggesting that the
transplanted human q-subunit GABAARs are picrotoxin
insensitive. Picrotoxin block of q-subunit GABAARs is
species specific and ineffective in rat, although heterolo-
gous expression of human q-subunit GABAARs are picro-
toxin sensitive (Zhang et al. 1995).
The histogram in Figure 2D summarizes results
obtained from oocytes, indicating that 50 lmol/L
GABA-elicited currents were largely blocked by each of
the a-subunit GABAAR antagonists: bicuculline, SR95531
and picrotoxin (tested at the ICmax values). Only small
percentage of the GABA currents were insensitive to
these antagonists, averaging 9.8  2% (n = 18),
7.2  2% (n = 16), and 12  4% (n = 18), respectively.
This remaining current was very similar to the average
current produced by 100 lmol/L CACA, 9.3  3%
(n = 12). These results indicate that the a-subunit
GABAAR is a major inhibitory receptor in human
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Figure 1. GABA- and muscimol-sensitive responses from the Xenopus oocytes transplanted with native human amygdala membrane fraction.
Sample voltage-clamp recordings from Xenopus oocytes microtransplanted with human amygdala plasma membrane in response to various
concentrations of GABA (A) or muscimol (B). (C) Average dose–response curves of GABA and muscimol. (D) Example of currents evoked by
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oocytes (n = 4). (F) GABA current in the sham-injected oocytes.
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amygdala and the q-subunit GABAAR constitutes a
minor component of the inhibitory input in human
amygdala. With this information we could evaluate the
interactions between metabotropic and the two types of
ionotropic GABA receptors.
The evidence of GABABR and its inhibitory
action
Both GABAARs and GABABRs are present in amygdala
(Li et al. 1996) and the relative effectiveness of muscimol
and GABA (see Fig. 1) suggested an interaction between
the two receptor pathways. Since muscimol does not acti-
vate GABABRs, we examined the current produced by
muscimol alone or in the presence of baclofen, a selective
GABABR agonist. Muscimol (10 lmol/L) elicited currents
were robustly suppressed by both 10 lmol/L and
100 lmol/L baclofen in a dose-dependent manner
(Fig 3A). The suppressive effect of baclofen could be fully
suppressed by 20 lmol/L CGP52432, a GABABR antago-
nist (Fig. 3B). However, 10 lmol/L baclofen, with or
without CGP52432, produced no effect on the resting
CA B
10 nA
5 s
GABA Bic
TPMPA
F
CACA TPMPA
5 s
1 nA
E
GABA
10
 n
A
5 s
SR (µmol/L)
10
5
2
1
0.5
0.2
0.1
GABA
10
 n
A
5 s
Bic (µmol/L)
100
50
20
10
5
1
0.5
50 µmol/L GABA
GABA+200 µmol/L PTX
20 nA
5 s
D
0
20
40
60
80
100
C
ur
re
nt
 (%
)
SR95531
Log [antagonist (µmol/L)]
0.1 1 10 100 1000
(n = 6) (n = 5) (n=5)
Bicuculline
Picrotoxin
Dose responses
G
50 µmol/L GABA +SR95531
+Picrotoxin CACA
+Bicuculline
100
50
7.2+29.8+212+4
(n = 18) (n = 18) (n = 16) (n = 12)(n = 52)      
C
ur
re
nt
 (%
)
9.3+3
* 
** 
*** 
Figure 2. Pharmacology of GABAA receptors from transplanted human amygdala. (A, B) Examples of dose-dependent inhibition of GABA
currents by SR95531 and bicuculline. (C) Dose-dependent inhibition curves of SR95531, bicuculline, and picrotoxin (PTX) against 50 lmol/L
GABA. (D) Histogram shows normalized average GABA currents alone and in the presence of PTX, bicuculline, or SR95531, as well as current
produced by CACA (cis-aminocrotonic acid). Statistically there was no difference between the CACA currents and the currents insensitive to
picrotoxin, bicuculline, or SR95531 (*, **, *** indicate P < 0.05, Student’s t-test). (E) A small TPMPA-sensitive GABA current observed when a-
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membrane currents prior to application of muscimol
(Fig. 3B, asterisk), indicating that activation of GABABRs
alone did not produce membrane currents in the oocytes.
The effect of baclofen on q-subunit GABAAR was also
tested in the transplanted oocytes. A typical example,
shown in Figure 3C, indicates that 10 lmol/L baclofen
had no detectable effect on CACA-elicited currents. On
average, 10 lmol/L baclofen suppressed 48  3%
(n = 12) of currents produced by 10 lmol/L muscimol,
but had no significant effect on 100 lmol/L CACA-eli-
cited currents (n = 8, Fig. 3D).
To verify the membrane expression of transplanted
GABABRs, immunolabeling of the oocytes was performed
using the specific antibody against the residues near the
C-terminus of GBR2 (anti-GBR2). The specificity of the
antibody for human amygdala fractions was tested in
Western blot assays. The anti-GBR2 clearly recognized a
single band of proteins with a molecular mass of 107
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Figure 3. Activation of GABABR inhibits a-subunit GABAAR currents. (A) 10 lmol/L and 100 lmol/L baclofen inhibit muscimol (10 lmol/L)-
evoked currents. (B) The suppressive effect of baclofen was blocked by 20 lmol/L CGP52432, a GABABR inhibitor; note that the baclofen with
and without CGP52432 have no effect on the resting membrane current (see asterisk). (C) Baclofen (10 lmol/L) did not suppress the CACA-
activated current. (D) Summary of the effects of 10 lmol/L baclofen on the currents produced by muscimol or CACA. On average, 10 lmol/L
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(Fig. 3E, left), consistent with the molecular mass of
GABABR II subunit. The anti-GBR2 labeling results indi-
cate that GABABRs were transported to the surface of the
Xenopus oocytes after injecting membrane fractions from
the human amgydala, but absent on the surface of oocytes
injected with a sham control (Fig. 3E), demonstrating
that GABABRs are not endogenously expressed in Xenopus
oocytes.
In another approach to test the suppressive effect of
baclofen on GABAAR currents, the anti-GBR2 antibody
was used to selectively disrupt GABABR function. Func-
tional GABABRs are heterodimers composed of GBR1
and GBR2 (Geng et al. 2013). The anti-GBR2 antibody
was applied in the membrane fraction sample with a vol-
ume ratio of 1:10,000 (antibody vs. membrane fraction
sample), then injected into Xenopus oocytes. After 24 h,
the effect of baclofen was tested on the oocytes with the
standard protocol: application of 10 lmol/L muscimol
with and without 100 lmol/L baclofen. In the presence of
the anti-GBR2, baclofen had a comparatively small effect
on the muscimol-elicited currents (Fig. 3F). On average,
with anti-GBR2 application, muscimol with and without
baclofen generated about 97.2  5.7% (n = 7) and
88.1 + 6% (n = 7) of the control muscimol-elicited cur-
rents, respectively. Application of anti-GBR2 had a minor
action on muscimol-activated GABAARs, but disrupted
the actions of GABABRs (Fig. 3G).
To confirm that baclofen’s effect was mediated by a
G-protein cascade, the nonhydrolyzable analog of guano-
sine-50-diphosphate (GDP), guanosine-50-O-(2-thiodipho-
sphate) trilithium salt (GDP-b-S), was injected into the
oocyte. GDP-b-S (100 lmol/L) injection suppressed the
effect of baclofen on the GABAA currents (Fig. 3H). This
was also consistent with the previous report that baclofen
does not act as a competitive antagonist at the GABAARs
(Xi et al. 1997).
Increasing GABAA response by inhibition of
GABABRs
To test the prediction that the response to GABA would
be enhanced if GABABRs were not activated, the potent
GABABR antagonists, CGP55845 and CGP52432, were
used to block GABABRs when GABA was applied. The
sample recordings shown in Figure 4A indicate that
10 lmol/L CGP55845 or 20 lmol/L CGP52432 increased
GABA (50 lmol/L)-elicited currents. This effect was pre-
sent in 11 of 19 transplanted oocytes obtained from dif-
ferent batches. Histograms from those 11 cells show that
average GABA currents in the presences of CGP55845 or
CGP52432 were increased to 142.5  13.2% (n = 11) or
131  6.2% (n = 11), respectively (Fig. 4B). In contrast,
when only GABAARs were activated with 10 lmol/L
muscimol, CGP52432 had no effect on muscimol-induced
currents (Fig. 4C), indicating that the GABABR antagonist
has no direct action on GABAARs.
Interaction between GABA receptors in
retinal ganglion cells
The effects of GABABRs on GABAAR currents were also
tested on neurons in the in vitro rodent retina slice
preparation. Neurons were recorded in the ganglion cell
layer using the whole-cell voltage-clamp technique and
were characterized by large voltage-activated sodium cur-
rents, typical of ganglion cells (Fig. 5A). Neurons were
held at various potentials between 90 and 10 mV and
either 30 lmol/L muscimol or muscimol plus 10 lmol/L
baclofen was focally applied. A typical experiment is
shown in Figure 5B, the averaged I–V curve from
A
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10 nA
5 s
10 nA
5 s
B
(n = 11) (n = 11)(n = 11)
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Figure 4. The GABA-elicited currents were increased when
blocking GABAB receptors (A). Both CGP55845 and CGP52432,
selective GABAB antagonists, increase GABA (50 lmol/L) currents in
transplanted oocytes. (B) The mean percentage increase of GABA
current by CGP55845 or CGP52432. In contrast, CGP52432 has no
effect on 10 lmol/L muscimol-elicited currents (C).
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recordings in seven neurons is shown in Figure 5C.
Baclofen suppressed muscimol-elicited inward and out-
ward currents (n = 7, Fig. 5B). When GDP-b-S
(100 lmol/L) was added to the pipette solution to block
activation of the G-protein cascade, the effect of baclofen
became negligible (Fig 5D, n = 5), which is consistent
with the results in Figure 3H. Because application of
GDP-b-S through a recording electrode could only inhibit
G-proteins in the local cells, it is possibly that the effect
of baclofen is via direct action on GABABRs in the local
ganglion cells, not from network inputs.
Discussion
Interactions between GABA receptor
subtypes
The findings, from both in vitro retina and transplanted
amygdala membrane, are that the GABABR can suppress
the inhibitory action of GABAARs. The results extend the
original observation in bullfrog dorsal root ganglion
(Xi et al. 1997) to the mammalian central nervous system
and indicate that this regulation may be a common fea-
ture at GABA synapses. These results contrast with find-
ings in thalamus and dentate gyrus, where the GABAAR
current was enhanced (Connelly et al. 2013; Tao et al.
2013). This enhancement was dependent on the presence
of d subunits in the GABAAR, a subunit that apparently
is not present in amygdala (Wisden et al. 1992). It sug-
gests that feed-forward crosstalk between GABA receptor
subtypes may be prevalent in the nervous system, but the
outcome may depend on the subunit composition of the
GABAAR.
The main mechanism of action of GABABRs in CNS is
to suppress voltage-dependent Ca2+ channels or to acti-
vate inward rectifying K+ channels. Both actions are inhi-
bitory, reducing transmitter release or causing membrane
hyperpolarization, respectively. The interesting finding
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Figure 5. Activation of GABABRs suppressed GABAAR currents in mouse retinal ganglion cells. (A) Example of the current–voltage relationship
of ganglion cells in whole-cell recording. (B) Baclofen suppressed muscimol-elicited currents in a ganglion cell clamped at various voltages.
(C) Average current–voltage relationship of muscimol-elicited currents with and without baclofen. (D) The effects of baclofen were blocked by
intracellular application of GDP-b-S (100 lmol/L).
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here is that activation of GABABRs suppressed GABAA
responses and this disinhibition occurs when both recep-
tors are present on the same cell.
The cross-talk between receptors that we observed
would have a net effect of increasing excitation. Although
this seems paradoxical for an inhibitory transmitter, it
has been repeatedly observed in retina. In rat retinal gan-
glion cells, the GABABR acts to suppress an N-type cal-
cium channel that is linked to a BK channel. Thus, the
effect of GABABR stimulation is to reduce an outward
potassium current, thereby promoting excitation (Garay-
cochea and Slaughter 2016). In salamander retina,
GABABRs promote excitatory synaptic input to ganglion
cells (Song and Slaughter 2010) and enhance L-type cal-
cium currents (Shen and Slaughter 1999). The present
results provide a third GABABR mechanism that can pro-
mote excitation.
The concept that GABABRs can counteract GABAAR
inhibition is not surprising since one frequent action of
metabotropic receptors is to reduce presynaptic release of
GABA (Deisz and Prince 1989; Chen and van den Pol
1998; Kobayashi et al. 2012). Furthermore, the GABABR
activation of inward rectifying potassium channels
(GIRKs) is a voltage-dependent inhibition that diminishes
with excitation. Thus, the metabotropic GABA receptor
seems to have multiple mechanisms to promote excitation
as well as suppress it.
GABA receptors from human amygdala
The microtransplantation technique inserts membrane
microdomains, containing an array of proteins and lipids
from native tissue (Miledi et al. 2006). This not only per-
mits examination of membrane protein function that is
difficult in the native tissue, but also allows for a mem-
brane complex to be inserted together. This is in contrast
to the transfection of one or a few known genes and may
be particularly relevant for GABAB receptors, where a
diversity of effects arise from auxiliary binding proteins
(Chalifoux and Carter 2011).
Amygdala microtransplantation revealed functional
expression of ionotropic receptors with the properties of
a-subunit and q-subunit GABAARs. The study provides
the first evidence of functional q-subunit GABAARs in
human amygdala, although the q-subunit GABAAR cur-
rent was only about 5% of the total GABAAR current.
The receptors had a distinctive pharmacological profile,
for example, sensitive to CACA, but only partially blocked
by TPMPA. It has been reported that q-subunit
GABAAR-mediated miniature IPSCs in rat amygdala are
partially sensitive to TPMPA (Delaney and Sah 2001).
Microtransplanted human amygdala membrane
demonstrated GABABRs based on immunohistochemistry
and functional studies. Multiple reports on mammalian
amygdala show GABABRs are widespread in basolateral
and central amygdala (Rainnie et al. 1991; Karlsson et al.
1992; Yamada et al. 1999; Delaney and Sah 2001). The
experiments indicated that the metabotropic receptor
could suppress a-subunit, but not q-subunit, containing
GABAARs. Since the q-subunit GABAARs have slower
kinetics than a-subunit GABAARs, the GABABR may alter
the time-dependent balance of GABAAR inhibition in the
amygdala. This could be important because the two
ionotropic receptors have different functions. Activation
of q-subunit GABAARs in the lateral amygdala enhances
the fear learning behavior (Cunha et al. 2010), as opposed
to the effect of a-subunit GABAAR activation, which sup-
presses emotional learning behaviors (Liu et al. 2014).
Furthermore, the GABAAR–GABABR interaction may also
depend on the subunit composition of the GABAAR.
Baclofen enhances tonic GABAAR current in several brain
regions where the GABAAR d-subunit is present (Con-
nelly et al. 2013; Tao et al. 2013), but with the opposite
effect in amygdala that lacks d-subunits (Wisden et al.
1992). Therefore, the experiments highlight the potential
diversity of control mechanisms produced by crosstalk
between GABAR subtypes.
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